THE SAFETY AND EFFICACY OF NEW DRUG APPROVAL Dale H. Gieringer The perception that agencies are out of control arises from the fact that in being called on to make fundamental…

1. Stimulus Bill 20091 2. ARRA – Guiding Principles • Priority given to: – quot;quick-start activitiesquot; • give preference to activities that can be started and…

Slide 1Improving Spontaneous Reporting: A new business model Incorporating postmarket medical product safety data collection into the clinical practice workflow at the point-of-care…

Slide 1© IFPMA 2009 IFPMA to WHO EWG 12 Jan 09 1 Alicia D. Greenidge, Director General, IFPMA WHO Expert Working Group, Geneva, 12 Jan 2009 IFPMA Presentation to WHO Expert…

Slide 1Is FDA failing us Or are we failing FDA? Jonathan C. Javitt, M.D.,M.P.H Senior Fellow, Potomac Institute for Policy Studies Former Chair, Health Subcommittee, Presidents…

Slide 1Evidence-based surgery: Are we there yet? Ivan Lester Memorial Lecture Cairns, 30 October 2014 Robyn McDermott Slide 2 Ivan Lester and staff, Cairns Hospital, 1950’s…

1. ANVISAAgencia Nacional de VigilanciaSanitariaBy Prashant Patel(M.pharm sem-2)Department of pharmaceuticaltechnologyIndukaka Ipcowala college of pharmacy 2. Background…

1.   2. Module 2 : The Role of the Food and Drug Administration and Key Regulations of New Prescribed Medications for Practitioners http://www.fda.gov/oc/history/historyoffda/section5.html…

1. Regulatory guidelines for promotion ofPrescription drugs in India . ©Mark IV Medical communication 2. The Organization ofPharmaceutical Producers of India (OPPI) has…

1. First Previous Next LastIndex Text Slide 1 of 17 2. First Previous Next LastIndex Text Slide 2 of 17 3. First Previous Next LastIndex TextSlide 17 of 17 4. Effects of…